A new conversation about clinical trial performance starts here.
Published by Applied Clinical Trials and sponsored by ArcheMedX, the new podcast series explores a simple but often overlooked reality: every clinical trial depends on human performance.
In the first episode, Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., introduces the learning, behavioral and cognitive science principles that will shape the conversations ahead, including why knowing does not always translate into doing and why understanding how people learn, decide and perform can reveal important risks long before they surface in trial execution.
Weโre grateful to Applied Clinical Trials for providing a platform for this discussion and excited for whatโs ahead.
Over the coming episodes, Brian will be joined by an exceptional group of guests spanning clinical research, human performance, behavioral science and cognitive science. Together, theyโll explore the human factors that influence trial quality, operational performance and risk across the study lifecycle.
Listen to the first episode and follow the series as these conversations unfold.
You can listen, share, and subscribe to the podcast here:
๐๐ฝ๐ฝ๐น๐ฒ ๐ฃ๐ผ๐ฑ๐ฐ๐ฎ๐๐๐: https://lnkd.in/e2_dZwvs
๐ฆ๐ฝ๐ผ๐๐ถ๐ณ๐ ๐ฃ๐ผ๐ฑ๐ฐ๐ฎ๐๐๐: https://lnkd.in/eDwCncNn
Or, you can listen and bookmark on the Applied Clinical Trials website: https://lnkd.in/eYmpQBa5
Related Post
Episode 2: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
The earliest signs of trial risk may appear before the first patient is ever enrolled.…
ArcheMedX Team
AI Will Not Close the Readiness Gap in Clinical Trials. It Will Expose It.
The risk in an AI-first trial is not that teams use the tools. It is…
Joel Selzer
The Earliest Warning Sign: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
Most protocol deviations start as human problems, not operational ones, but risk-based monitoring typically relies…
